Annual Mortality In A Large Prevalence-Based Sample Of United States Rheumatoid Arthritis Patients

Abstract

Among AS patients receiving their first biologic, disease severity differed within 5EU, with patients in the UK with relatively higher burden and poorer treatment response. Impact of specific biologic treatments on the observed patterns warrants further scrutiny.